GATA-4 upregulates glucose-dependent insulinotropic polypeptide expression in cells of pancreatic and intestinal lineage

Molecular and Cellular Endocrinology

Volumn 287, Issue 1-2, 2008, Pages 20-29

  Jepeal, Lisa I ^a   Boylan, Michael O ^a   Michael Wolfe, M ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

GATA 4; Gene expression; GIP; Glucose dependent insulinotropic polypeptide; Insulin; ISL 1; PDX 1

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; MESSENGER RNA; TRANSCRIPTION FACTOR GATA 4;

ARTICLE; CELL LINEAGE; CELL SUBPOPULATION; DUODENUM; GENE EXPRESSION; GENETIC TRANSFECTION; INTESTINE CELL; MOUSE; NONHUMAN; PANCREAS CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE;

ANIMALS; BIOLOGICAL ASSAY; CELL LINE; CELL LINEAGE; GASTRIC INHIBITORY POLYPEPTIDE; GATA4 TRANSCRIPTION FACTOR; HOMEODOMAIN PROTEINS; INTESTINES; LUCIFERASES; MICE; PANCREAS; PROMOTER REGIONS (GENETICS); RATS; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANS-ACTIVATORS; UP-REGULATION;

EID: 43549103295     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2008.01.024     Document Type: Article

References (49)

1. Ahlgren U., Jonsson J., Jonsson L., Simu K., and Edlund H. Beta-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes. Genes Dev. 12 (1998) 1763-1768
2. Boudreau F., Rings E.H., van Wering H.M., Kim R.K., Swain G.P., Krasinski S.D., Moffett J., Grand R.J., Suh E.R., and Traber P.G. Hepatocyte nuclear factor-1 alpha, GATA-4, and caudal related homeodomain protein Cdx2 interact functionally to modulate intestinal gene transcription. Implication for the developmental regulation of the sucrase-isomaltase gene. J. Biol. Chem. 277 (2002) 31909-31917
3. Boyer D.F., Fujitani Y., Gannon M., Powers A.C., Stein R.W., and Wright C.V. Complementation rescue of Pdx1 null phenotype demonstrates distinct roles of proximal and distal cis-regulatory sequences in pancreatic and duodenal expression. Dev. Biol. 298 (2006) 616-631
4. Boylan M.O., Jepeal L.I., Jarboe L.A., and Wolfe M.M. Cell-specific expression of the glucose-dependent insulinotropic polypeptide gene in a mouse neuroendocrine tumor cell line. J. Biol. Chem. 272 (1997) 17438-17443
5. Brissova M., Shiota M., Nicholson W.E., Gannon M., Knobel S.M., Piston D.W., Wright C.V., and Powers A.C. Reduction in pancreatic transcription factor PDX-1 impairs glucose-stimulated insulin secretion. J. Biol. Chem. 277 (2002) 11225-11232
6. Brubaker P.L., Schloos J., and Drucker D.J. Regulation of glucagon-like peptide-1 synthesis and secretion in the GLUTag enteroendocrine cell line. Endocrinology 139 (1998) 4108-4114
7. Buchan A.M., Polak J.M., Capella C., Solcia E., and Pearse A.G. Electronimmunocytochemical evidence for the K cell localization of gastric inhibitory polypeptide (GIP) in man. Histochemistry 56 (1978) 37-44
8. Carey M. The enhanceosome and transcriptional synergy. Cell 92 (1998) 5-8
9. Cataland S., Crockett S.E., Brown J.C., and Mazzaferri E.L. Gastric inhibitory polypeptide (GIP) stimulation by oral glucose in man. J. Clin. Endocrinol. Metab. 39 (1974) 223-228
10. Cheung A.D.B., Lewis J.T., Korbutt G.S., Rajotte R.V., Bryer-Ash M., Boylan M.O., Wolfe M.M., and Kieffer T.J. Glucose-dependent insulin release form genetically engineered K cells. Science 290 (2000) 1959-1962
11. D'Ambra R., Surana M., Efrat S., Starr R.G., and Fleischer N. Regulation of insulin secretion from beta-cell lines derived from transgenic mice insulinomas resembles that of normal beta-cells. Endocrinology 126 (1990) 2815-2822
12. Divine J.K., Staloch L.J., Haveri H., Jacobsen C.M., Wilson D.B., Heikinheimo M., and Simon T.C. GATA-4, GATA-5, and GATA-6 activate the rat liver fatty acid binding protein gene in concert with HNF-1alpha. Am. J. Physiol. Gastrointest. Liver Physiol. 287 (2004) G1086-G1099
13. Dusing M.R., Florence E.A., and Wiginton D.A. High-level activation by a duodenum-specific enhancer requires functional GATA binding sites. Am. J. Physiol. Gastrointest. Liver Physiol. 284 (2003) G1053-G1065
14. Dusing M.R., Florence E.A., and Wiginton D.A. Pdx-1 is required for activation in vivo from a duodenum-specific enhancer. J. Biol. Chem. 276 (2001) 14434-14442
15. Efrat S., Linde S., Kofod H., Spector D., Delannoy M., Grant S., Hanahan D., and Baekkeskov S. Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 9037-9041
16. Fang R., Olds L.C., Santiago N.A., and Sibley E. GATA family transcription factors activate lactase gene promoter in intestinal Caco-2 cells. Am. J. Physiol. Gastrointest. Liver Physiol. 280 (2001) G58-G67
17. Gao X., Sedgwick T., Shi Y.B., and Evans T. Distinct functions are implicated for the GATA-4, -5, and -6 transcription factors in the regulation of intestine epithelial cell differentiation. Mol. Cell. Biol. 18 (1998) 2901-2911
18. Gault V.A., O'Harte F.P., Harriott P., Mooney M.H., Green B.D., and Flatt P.R. Effects of the novel (Pro(3))GIP antagonist and exendin(9-39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin. Diabetologia 46 (2003) 222-230
19. Gutniak M., Orskov C., Holst J.J., Ahren B., and Efendic S. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. N. Engl. J. Med. 326 (1992) 1316-1322
20. Jenny M., Uhl C., Roche C., Duluc I., Guillermin V., Guillemot F., Jensen J., Kedinger M., and Gradwohl G. Neurogenin3 is differentially required for endocrine cell fate specification in the intestinal and gastric epithelium. EMBO J. 21 (2002) 6338-6347
21. Jensen J., Pedersen E.E., Galante P., Hald J., Heller R.S., Ishibashi M., Kageyama R., Guillemot F., Serup P., and Madsen O.D. Control of endodermal endocrine development by Hes-1. Nat. Genet. 24 (2000) 36-44
22. Jepeal L.I., Boylan M.O., and Wolfe M.M. Cell-specific expression of the glucose-dependent insulinotropic polypeptide gene functions through a GATA and an ISL-1 motif in a mouse neuroendocrine tumor cell line. Regul. Pept. 113 (2003) 139-147
23. Jepeal L.I., Fujitani Y., Boylan M.O., Wilson C.N., Wright C.V., and Wolfe M.M. Cell-specific expression of glucose-dependent-insulinotropic polypeptide is regulated by the transcription factor PDX-1. Endocrinology 146 (2005) 383-391
24. Jonsson J., Carlsson L., Edlund T., and Edlund H. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 371 (1994) 606-609
25. Kayahara T., Sawada M., Takaishi S., Fukui H., Seno H., Fukuzawa H., Suzuki K., Hiai H., Kageyama R., Okano H., and Chiba T. Candidate markers for stem and early progenitor cells, Musashi-1 and Hes1, are expressed in crypt base columnar cells of mouse small intestine. FEBS Lett. 535 (2003) 131-135
26. Kieffer T.J., Huang Z., McIntosh C.H., Buchan A.M., Brown J.C., and Pederson R.A. Gastric inhibitory polypeptide release from a tumor-derived cell line. Am. J. Physiol. 269 (1995) E316-E322
27. Kiela P.R., LeSueur J., Collins J.F., and Ghishan F.K. Transcriptional regulation of the rat NHE3 gene. Functional interactions between GATA-5 and Sp family transcription factors. J. Biol. Chem. 278 (2003) 5659-5668
28. Marshman E., Booth C., and Potten C.S. The intestinal epithelial stem cell. Bioessays 24 (2002) 91-98
29. Matsuoka T.A., Zhao L., Artner I., Jarrett H.W., Friedman D., Means A., and Stein R. Members of the large Maf transcription family regulate insulin gene transcription in islet beta cells. Mol. Cell Biol. 23 (2003) 6049-6062
30. Mitchell P.J., and Tjian R. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science 245 (1989) 371-378
31. Murphy M.C., Isherwood S.G., Sethi S., Gould B.J., Wright J.W., Knapper J.A., and Williams C.M. Postprandial lipid and hormone responses to meals of varying fat contents: modulatory role of lipoprotein lipase?. Eur. J. Clin. Nutr. 49 (1995) 578-588
32. Nauck M.A., Holst J.J., Willms B., and Schmiegel W. Glucagon-like peptide 1 (GLP-1) as a new therapeutic approach for type 2-diabetes. Exp. Clin. Endocrinol. Diabetes 105 (1997) 187-195
33. Offield M.F., Jetton T.L., Labosky P.A., Ray M., Stein R.W., Magnuson M.A., Hogan B.L., and Wright C.V. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 122 (1996) 983-995
34. O'Harte F.P., Gray A.M., and Flatt P.R. Gastric inhibitory polypeptide and effects of glycation on glucose transport and metabolism in isolated mouse abdominal muscle. J. Endocrinol. 156 (1998) 237-243
35. Orkin S.H. GATA-binding transcription factors in hematopoietic cells. Blood 80 (1992) 575-581
36. Pederson R.A., Schubert H.E., and Brown J.C. Gastric inhibitory polypeptide. Its physiologic release and insulinotropic action in the dog. Diabetes 24 (1975) 1050-1056
37. Peers B., Leonard J., Sharma S., Teitelman G., and Montminy M.R. Insulin expression in pancreatic islet cells relies on cooperative interactions between the helix loop helix factor E47 and the homeobox factor STF-1. Mol. Endocrinol. 8 (1994) 1798-1806
38. Philippe J., Chick W.L., and Habener J.F. Multipotential phenotypic expression of genes encoding peptide hormones in rat insulinoma cell lines. J. Clin. Invest. 79 (1987) 351-358
39. Philippe J., Powers A.C., Mojsov S., Drucker D.J., Comi R., and Habener J.F. Expression of peptide hormone genes in human islet cell tumors. Diabetes 37 (1988) 1647-1651
40. Ramshur E.B., Rull T.R., and Wice B.M. Novel insulin/GIP co-producing cell lines provide unexpected insights into Gut K-cell function in vivo. J. Cell Physiol. 192 (2002) 339-350
41. Rindi G., Grant S.G., Yiangou Y., Ghatei M.A., Bloom S.R., Bautch V.L., Solcia E., and Polak J.M. Development of neuroendocrine tumors in the gastrointestinal tract of transgenic mice. Heterogeneity of hormone expression. Am. J. Pathol. 136 (1990) 1349-1363
42. Rindi G., Ratineau C., Ronco A., Candusso M., Tsai M., and Leiter A. Targeted ablation of secretin-producing cells in transgenic mice reveals a common differentiation pathway with multiple enteroendocrine cell lineages in the small intestine. Development 126 (1999) 4149-4156
43. 2+ in two enteroendocrine cell lines, STC-1 and GLUTag. J. Physiol. 528 Pt 1 (2000) 165-176
44. Skipper M., and Lewis J. Getting to the guts of enteroendocrine differentiation. Nat. Genet. 24 (2000) 3-4
45. Traber P.G., and Silberg D.G. Intestine-specific gene transcription. Annu. Rev. Physiol. 58 (1996) 275-297
46. Tseng C.C., Kieffer T.J., Jarboe L.A., Usdin T.B., and Wolfe M.M. Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat. J. Clin. Investig. 98 (1996) 2440-2445
47. Usdin T.B., Mezey E., Button D.C., Brownstein M.J., and Bonner T.I. Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. Endocrinology 133 (1993) 2861-2870
48. Yeung C.M., Wong C.K., Chung S.K., Chung S.S., and Chow B.K. Glucose-dependent insulinotropic polypeptide gene expression in the stomach: revealed by a transgenic mouse study, in situ hybridization and immunohistochemical staining. Mol. Cell Endocrinol. 154 (1999) 161-170
49. Yip R.G., Boylan M.O., Kieffer T.J., and Wolfe M.M. Functional GIP receptors are present on adipocytes. Endocrinology 139 (1998) 4004-4007